National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 988325

History of Changes from the VAERS Wayback Machine

First Appeared on 2/4/2021

VAERS ID: 988325
VAERS Form:2
Age:60.0
Sex:Female
Location:Michigan
Vaccinated:2021-01-06
Onset:2021-01-26
Submitted:0000-00-00
Entered:2021-01-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 025L20A / 1 LA / IM

Administered by: Private      Purchased by: ??
Symptoms: Biopsy skin, Petechiae, Purpura, Rash

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Hydrochlorothiazide last taken 2 weeks prior to vaccine administration Levothyroxine Albuterol as needed Daily multivitamin
Current Illness: None.
Preexisting Conditions: Anxiety, HLD, HTN, hypothyroidism, rosacea, liver steatosis secondary to obesity Migraine, impaired fasting glucose without diagnosis of T2DM, obesity with BMI 40.5
Allergies: Codeine and morphine intolerance Sulfa antibiotics-prior hives seen on administration in her 20s
Diagnostic Lab Data: Punch biopsy of rash with result pending at time of report.
CDC 'Split Type':

Write-up: Onset of Petechial/purpural rash along BLE starting in thighs B/L with spread to abdomen and BUE. Probable Type III Hypersensitivity vs vasculitis. Came to hospital 01/28/2021. Treated with PO steroids 60 mg PO prednisone with rapid improvement. Testing still pending.


Changed on 2/12/2021

VAERS ID: 988325 Before After
VAERS Form:2
Age:60.0
Sex:Female
Location:Michigan
Vaccinated:2021-01-06
Onset:2021-01-26
Submitted:0000-00-00
Entered:2021-01-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 025L20A / 1 LA / IM

Administered by: Private      Purchased by: ??
Symptoms: Biopsy skin, Petechiae, Purpura, Rash, Vasculitis, Type III immune complex mediated reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Hydrochlorothiazide last taken 2 weeks prior to vaccine administration Levothyroxine Albuterol as needed Daily multivitamin
Current Illness: None.
Preexisting Conditions: Anxiety, HLD, HTN, hypothyroidism, rosacea, liver steatosis secondary to obesity Migraine, impaired fasting glucose without diagnosis of T2DM, obesity with BMI 40.5
Allergies: Codeine and morphine intolerance Sulfa antibiotics-prior hives seen on administration in her 20s
Diagnostic Lab Data: Punch biopsy of rash with result pending at time of report.
CDC 'Split Type':

Write-up: Onset of Petechial/purpural rash along BLE starting in thighs B/L with spread to abdomen and BUE. Probable Type III Hypersensitivity vs vasculitis. Came to hospital 01/28/2021. Treated with PO steroids 60 mg PO prednisone with rapid improvement. Testing still pending.


Changed on 5/7/2021

VAERS ID: 988325 Before After
VAERS Form:2
Age:60.0
Sex:Female
Location:Michigan
Vaccinated:2021-01-06
Onset:2021-01-26
Submitted:0000-00-00
Entered:2021-01-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 025L20A / 1 LA / IM

Administered by: Private      Purchased by: ??
Symptoms: Biopsy skin, Petechiae, Purpura, Rash, Vasculitis, Type III immune complex mediated reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Hydrochlorothiazide last taken 2 weeks prior to vaccine administration Levothyroxine Albuterol as needed Daily multivitamin
Current Illness: None.
Preexisting Conditions: Anxiety, HLD, HTN, hypothyroidism, rosacea, liver steatosis secondary to obesity Migraine, impaired fasting glucose without diagnosis of T2DM, obesity with BMI 40.5
Allergies: Codeine and morphine intolerance Sulfa antibiotics-prior hives seen on administration in her 20s 20s
Diagnostic Lab Data: Punch biopsy of rash with result pending at time of report.
CDC 'Split Type':

Write-up: Onset of Petechial/purpural rash along BLE starting in thighs B/L with spread to abdomen and BUE. Probable Type III Hypersensitivity vs vasculitis. Came to hospital 01/28/2021. Treated with PO steroids 60 mg PO prednisone with rapid improvement. Testing still pending.


Changed on 5/14/2021

VAERS ID: 988325 Before After
VAERS Form:2
Age:60.0
Sex:Female
Location:Michigan
Vaccinated:2021-01-06
Onset:2021-01-26
Submitted:0000-00-00
Entered:2021-01-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 025L20A / 1 LA / IM

Administered by: Private      Purchased by: ??
Symptoms: Biopsy skin, Petechiae, Purpura, Rash, Vasculitis, Type III immune complex mediated reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? Yes, days: 3     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Hydrochlorothiazide last taken 2 weeks prior to vaccine administration Levothyroxine Albuterol as needed Daily multivitamin
Current Illness: None.
Preexisting Conditions: Anxiety, HLD, HTN, hypothyroidism, rosacea, liver steatosis secondary to obesity Migraine, impaired fasting glucose without diagnosis of T2DM, obesity with BMI 40.5
Allergies: Codeine and morphine intolerance Sulfa antibiotics-prior hives seen on administration in her 20s 20s
Diagnostic Lab Data: Punch biopsy of rash with result pending at time of report.
CDC 'Split Type':

Write-up: Onset of Petechial/purpural rash along BLE starting in thighs B/L with spread to abdomen and BUE. Probable Type III Hypersensitivity vs vasculitis. Came to hospital 01/28/2021. Treated with PO steroids 60 mg PO prednisone with rapid improvement. Testing still pending.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=988325&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166